cephalosporin c has been researched along with Hepatitis C in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, R; Kumar, V; Lee, KW | 1 |
| Allaz, AF; Balant, L; Belaieff, J; Cochet, B; Fabre, J; Rudhardt, M | 1 |
| Malnick, SD; Somin, M; Sthoeger, ZM; Zimchoni, O | 1 |
| Black, D; Fritsche, TR; Gautom, RK; Limaye, AP | 1 |
4 other study(ies) available for cephalosporin c and Hepatitis C
| Article | Year |
|---|---|
A computational drug repurposing approach in identifying the cephalosporin antibiotic and anti-hepatitis C drug derivatives for COVID-19 treatment.
Topics: Ceftaroline; Cephalosporins; Coronavirus 3C Proteases; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Hepacivirus; Hepatitis C; Humans; Molecular Dynamics Simulation; Oligopeptides; SARS-CoV-2 | 2021 |
[Pharmacokinetic study of a cephalosporin, cefoperazone, in liver failure].
Topics: Adult; Cefoperazone; Cephalosporins; Fatty Liver, Alcoholic; Female; Hepatitis A; Hepatitis B; Hepatitis C; Humans; Kinetics; Liver Cirrhosis, Alcoholic; Liver Diseases; Male; Metabolic Clearance Rate; Middle Aged | 1981 |
Spontaneous bacterial empyema in a patient with hepatitis C virus cirrhosis and sterile ascitic fluid.
Topics: Ascitic Fluid; Bacterial Infections; Ceftriaxone; Cephalosporins; Empyema, Pleural; Escherichia coli Infections; Female; Hepatitis C; Humans; Liver Cirrhosis; Middle Aged | 1996 |
Rapid emergence of resistance to cefepime during treatment.
Topics: Cefepime; Cephalosporin Resistance; Cephalosporins; Enterobacter; Enterobacteriaceae Infections; Hepatitis C; Humans; Liver Abscess; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Failure | 1997 |